Colorectal Cancer Clinical Trials in Los Angeles, California

30 studies are recruiting for colorectal cancer in Los Angeles, California right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies, page 2

  1. An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia.

    A multi-center evaluation of NGM120 in a randomized, double-blind, placebo-controlled study in participants with colorectal cancer who have cancer cachexia.

    Stage
    Phase 2
    Ages
    18 and older
    Site
    NGM Clinical Study Site, Los Angeles, California
    Locations
    28 in total
    Run by
    NGM Biopharmaceuticals, Inc

    See if you can join NCT07033026 on ClinicalTrials.gov

  2. Community Partnership for Telehealth Solutions to Convey Information and Enhance Care

    Non-randomized, two-arm stepped-wedge trial of a multi-level colorectal cancer screening intervention.

    Stage
    Not phased
    Ages
    45 to 64
    Site
    AltaMed Health Services Corporation, Los Angeles, California
    Run by
    University of Arizona

    See if you can join NCT06542835 on ClinicalTrials.gov

  3. A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression

    The goal of this study is to test A2B395, an allogeneic logic-gated Tmod™ CAR T-cell product in subjects with solid tumors including colorectal cancer (CRC), non-small cell lung cancer (NSCLC), head and neck squamous cell carcinoma (HNSCC), triple-negative breast cancer (TNBC), renal cell carcinoma…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    UCLA Medical Center, Los Angeles, California
    Locations
    10 in total
    Run by
    A2 Biotherapeutics Inc.

    See if you can join NCT06682793 on ClinicalTrials.gov

  4. Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors

    The investigational drug to be studied in this protocol, BCA101, is a first-in-class compound that targets both EGFR with TGFβ. Based on preclinical data, this bifunctional antibody may exert synergistic activity in patients with EGFR-driven tumors.

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Keck School of Medicine of USC, Los Angeles, California
    Locations
    20 in total
    Run by
    Bicara Therapeutics

    See if you can join NCT04429542 on ClinicalTrials.gov

  5. ColoCare Study - Colorectal Cancer Cohort

    ColoCare is an international prospective cohort study of stage I-IV colorectal cancer patients (ICD-10 C18-C20).

    Stage
    Not phased
    Ages
    18 to 89
    Site
    Cedars-Sinai Medical Center, Los Angeles, California
    Locations
    7 in total
    Run by
    University of Utah

    See if you can join NCT02328677 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.